The Duke-UNC Comprehensive Sickle Cell Center proposes the establishment of a new division, the Division of Policy and Ethics, whose purpose it would be to study and to affect a range of issues not conveniently examined by working groups organized in strictly disciplinary fashion. The Division of Policy and Ethics would consider, over five years, the sickle-cell aspects of the following: general health policy; clinical guideline development, dissemination, and effect; patient tracking; professional standards development for genetic counseling; complex clinical decision-making and technology assessment; cost-effectiveness analysis; and research ethics, clinical ethics, and """"""""political"""""""" (or """"""""policy"""""""") ethics. Analytical techniques, necessarily various, would include the following: analysis of pre-existing data (such as databases and charts); observational research (as in the study of practice patterns); survey research (as in the study of patient experiences and preferences [in partnership with the Psychosocial and Clinical Divisions]); formal decision analysis (as in the specification of algorithms of care); microeconomic analysis (as in cost-effectiveness analysis); prospective clinical research (in partnership with the Clinical Division); and formal philosophical discourse (as in ethical analysis). Services provided would include services to the Center (such as consultation with other Divisions, and enhancement of collaborations with other Centers and other institutions), and services to the sickle cell community. The latter will include yearly symposia held either in the Duke-UNC area or at regional or national meetings, and the production of annotated bibliographies of policy and ethics literature related to sickle cell disease. Internal advice (as well as material and substantive intellectual assistance) would come from the already-existing Divisions. Outside advice and periodic critical review would be sought from a Board of Advisors composed of professional and lay members of the sickle cell community, local and national.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL028391-14
Application #
5213392
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Ariens, Robert A S; Lai, Thung-Shenq; Weisel, John W et al. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743-54
Ware, Russell E; Eggleston, Barry; Redding-Lallinger, Rupa et al. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99:10-4
Thompson Jr, Robert J; Gustafson, Kathryn E; Bonner, Melanie J et al. (2002) Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol 27:235-44
Slaughter, T F; Sreeram, G; Sharma, A D et al. (2001) Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 12:85-93
Lai, T S; Hausladen, A; Slaughter, T F et al. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40:4904-10
Ataga, K I; Orringer, E P (2000) Renal abnormalities in sickle cell disease. Am J Hematol 63:205-11
Ataga, K I; Orringer, E P (2000) Bone marrow necrosis in sickle cell disease: a description of three cases and a review of the literature. Am J Med Sci 320:342-7
Kinney, T R; Helms, R W; O'Branski, E E et al. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 94:1550-4
Lai, T S; Slaughter, T F; Peoples, K A et al. (1999) Site-directed mutagenesis of the calcium-binding site of blood coagulation factor XIIIa. J Biol Chem 274:24953-8
Slentz-Kesler, K A; Hale, L P; Kaufman, R E (1998) Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 47:327-40

Showing the most recent 10 out of 78 publications